Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AGILENT TECHNOLOGIES, INC. | Director | Common Stock | 56.7K | $8.36M | $147.48 | Mar 15, 2024 | Heidi K. Fields Living Trust |
Phathom Pharmaceuticals, Inc. | Director | Common Stock | 19.5K | $178K | $9.11 | May 23, 2024 | Direct |
Icosavax, Inc. | Former Director | Common Stock | 0 | $0 | $15.29 | Feb 19, 2024 | Direct |
Phathom Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 17.5K | May 23, 2024 | Direct | ||
Icosavax, Inc. | Former Director | Stock Option (Right to Buy) | 0 | Feb 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PHAT | Phathom Pharmaceuticals, Inc. | May 23, 2024 | 2 | $0 | 4 | May 24, 2024 | Director |
A | AGILENT TECHNOLOGIES, INC. | Mar 15, 2024 | 1 | $247K | 4 | Mar 19, 2024 | Director |
A | AGILENT TECHNOLOGIES, INC. | Mar 5, 2024 | 1 | -$239K | 4 | Mar 7, 2024 | Director |
ICVX | Icosavax, Inc. | Feb 19, 2024 | 5 | $0 | 4 | Feb 20, 2024 | Former Director |
ICVX | Icosavax, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
PHAT | Phathom Pharmaceuticals, Inc. | May 25, 2023 | 2 | $0 | 4 | May 30, 2023 | Director |
A | AGILENT TECHNOLOGIES, INC. | Mar 16, 2023 | 1 | $227K | 4 | Mar 20, 2023 | Director |
A | AGILENT TECHNOLOGIES, INC. | Nov 23, 2022 | 1 | -$566K | 4 | Nov 28, 2022 | Director |
ICVX | Icosavax, Inc. | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
PHAT | Phathom Pharmaceuticals, Inc. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
A | AGILENT TECHNOLOGIES, INC. | Mar 17, 2022 | 1 | $244K | 4 | Mar 21, 2022 | Director |
ICVX | Icosavax, Inc. | Jul 30, 2021 | 1 | $131K | 4 | Aug 2, 2021 | Director |
ICVX | Icosavax, Inc. | Jul 28, 2021 | 0 | $0 | 3 | Jul 28, 2021 | Director |
PHAT | Phathom Pharmaceuticals, Inc. | May 21, 2021 | 1 | $0 | 4 | May 24, 2021 | Director |